Department of Anesthesiology, Washington University in St Louis, St Louis, Missouri, USA
Department of Psychiatry, University of California San Francisco, San Francisco, California, USA.
Thorax. 2022 Jan;77(1):13-21. doi: 10.1136/thoraxjnl-2021-217158. Epub 2021 Jul 12.
Using latent class analysis (LCA), two subphenotypes of acute respiratory distress syndrome (ARDS) have consistently been identified in five randomised controlled trials (RCTs), with distinct biological characteristics, divergent outcomes and differential treatment responses to randomised interventions. Their existence in unselected populations of ARDS remains unknown. We sought to identify subphenotypes in observational cohorts of ARDS using LCA.
LCA was independently applied to patients with ARDS from two prospective observational cohorts of patients admitted to the intensive care unit, derived from the Validating Acute Lung Injury markers for Diagnosis (VALID) (n=624) and Early Assessment of Renal and Lung Injury (EARLI) (n=335) studies. Clinical and biological data were used as class-defining variables. To test for concordance with prior ARDS subphenotypes, the performance metrics of parsimonious classifier models (interleukin 8, bicarbonate, protein C and vasopressor-use), previously developed in RCTs, were evaluated in EARLI and VALID with LCA-derived subphenotypes as the gold-standard.
A 2-class model best fit the population in VALID (p=0.0010) and in EARLI (p<0.0001). Class 2 comprised 27% and 37% of the populations in VALID and EARLI, respectively. Consistent with the previously described 'hyperinflammatory' subphenotype, Class 2 was characterised by higher proinflammatory biomarkers, acidosis and increased shock and worse clinical outcomes. The similarities between these and prior RCT-derived subphenotypes were further substantiated by the performance of the parsimonious classifier models in both cohorts (area under the curves 0.92-0.94). The hyperinflammatory subphenotype was associated with increased prevalence of chronic liver disease and neutropenia and reduced incidence of chronic obstructive pulmonary disease. Measurement of novel biomarkers showed significantly higher levels of matrix metalloproteinase-8 and markers of endothelial injury in the hyperinflammatory subphenotype, whereas, matrix metalloproteinase-9 was significantly lower.
Previously described subphenotypes are generalisable to unselected populations of non-trauma ARDS.
使用潜在类别分析(LCA),在五项随机对照试验(RCT)中,急性呼吸窘迫综合征(ARDS)的两个亚表型已被一致确定,具有不同的生物学特征、不同的结局和对随机干预的不同治疗反应。它们在ARDS 的未选择人群中的存在尚不清楚。我们试图使用 LCA 在 ARDS 的观察队列中识别亚表型。
LCA 独立应用于从两个前瞻性观察性 ARDS 患者队列中入院的重症监护病房患者,这两个队列分别来自 Validating Acute Lung Injury markers for Diagnosis(VALID)(n=624)和 Early Assessment of Renal and Lung Injury(EARLI)(n=335)研究。临床和生物学数据被用作类别定义变量。为了测试与先前 ARDS 亚表型的一致性,在 EARLI 和 VALID 中评估了先前在 RCT 中开发的简洁分类器模型(白细胞介素 8、碳酸氢盐、蛋白 C 和血管加压素使用)的性能指标,这些模型以 LCA 衍生的亚表型为金标准。
VALID(p=0.0010)和 EARLI(p<0.0001)中 2 类模型最适合人群。VALID 和 EARLI 中的第 2 类分别占人群的 27%和 37%。与先前描述的“高炎症”亚表型一致,第 2 类的特点是更高的促炎生物标志物、酸中毒、增加的休克和更差的临床结局。这些与先前 RCT 衍生的亚表型之间的相似性通过简洁分类器模型在两个队列中的性能进一步证实(曲线下面积 0.92-0.94)。高炎症亚表型与慢性肝病和中性粒细胞减少症的患病率增加以及慢性阻塞性肺疾病的发病率降低有关。新型生物标志物的测量显示,高炎症亚表型中基质金属蛋白酶-8 和内皮损伤标志物的水平显著升高,而基质金属蛋白酶-9 的水平显著降低。
先前描述的亚表型可推广到非创伤性 ARDS 的未选择人群。